R Shinebaum

407 citations
16 papers · 323 indexed · h-index 10
Topics
Spondyloarthritis Studies and Treatments (8 papers)Psoriasis: Treatment and Pathogenesis (4 papers)Antibiotic Resistance in Bacteria (3 papers)
Partner nations
United KingdomIreland

In The Last Decade

R Shinebaum

16 papers receiving 280 citations

Peers

R Shinebaum
Comparison fields: 5 of 73
  • Rheumatology 161
  • Immunology 73
  • Molecular Biology 71
  • Genetics 52
  • Epidemiology 48
Replace Henry Søgaard with:
Henry Søgaard Denmark
Faramarz Derakhshan Iran
M. W. Burns Australia
Elena Riera Spain
R.A. Gargan United Kingdom
L G Tallgren Finland
Ramandeep Singh Netherlands
Monthida Fangtham United States
S. L. Hill United Kingdom
Tad Eichler United States
R Shinebaum relative to Henry Søgaard Denmark Henry Søgaard's profile →
Citations per field
00.5×3.5×
Henry Søgaard · 1×
Citations per year

Countries citing papers authored by R Shinebaum

Since Specialization
Citations

This map shows the geographic impact of R Shinebaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Shinebaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Shinebaum more than expected).

Fields of papers citing papers by R Shinebaum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Shinebaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Shinebaum. The network helps show where R Shinebaum may publish in the future.

Co-authorship network of co-authors of R Shinebaum

This figure shows the co-authorship network connecting the top 25 collaborators of R Shinebaum. A scholar is included among the top collaborators of R Shinebaum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Shinebaum. R Shinebaum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 5
2 43
3 32
4 25
5 9
6 9
7 23
8 8
9 33
10 12
11 54
12 8
13 16
14 16
15
Transfer of invertase production from a wild strain of Escherichia coli.
5
16 25

About R Shinebaum

R Shinebaum is a scholar working on Molecular Medicine, Rheumatology and Endocrinology, having authored 16 papers that have together received 323 indexed citations. Recurring topics across this work include Spondyloarthritis Studies and Treatments (8 papers), Psoriasis: Treatment and Pathogenesis (4 papers) and Antibiotic Resistance in Bacteria (3 papers). The work is most often cited by research in Rheumatology (161 citations), Endocrinology (35 citations) and Molecular Medicine (27 citations). R Shinebaum has collaborated with scholars based in United Kingdom and Ireland. Frequent co-authors include E. M. Cooke, V Wright, Vera Neumann, C J Eastmond, H E Willshaw, Meral Çalgünerı, Layinka Swinburne, A. S. Edmondson, C C Blackwell and P J Forster. Their work appears in journals such as Annals of the Rheumatic Diseases, Lara D. Veeken and FEMS Microbiology Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026